HDACis inhibit the activity of cancer stem cells by targeting several essential genes involved in cancer stem cell maintenance, such as those encoding β, γ-catenin, Stat3, and Notch1, thereby reducing tumor development [83]. This evidence concerns the gene STAT3 and cancer.